Paclitaxel (taxol)-induced NF-κB translocation in murine macrophages

Infection and Immunity

Volumn 64, Issue 3, 1996, Pages 878-884

  Perera, Pin Yu ^a   Qureshi, Nilofer ^b,c   Vogel, Stefanie N ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; PACLITAXEL; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; DOSE RESPONSE; FEMALE; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RHODOBACTER SPHAEROIDES; TRANSCRIPTION INITIATION;

EID: 0030021823     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.3.878-884.1996     Document Type: Article

References (48)

1. Baeuerle, P. A., and T. Henkel. 1994 Function and activation of NF-κB in the immune system Annu. Rev. Immunol 12:141-179.
2. Beg, A. A., and A. S. Baldwin. 1993. The IκB proteins: multifunctional regulators of rel/NF-κB transcription factors. Genes Dev. 7:2064-2070.
3. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature (London) 376:167-170.
4. Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway Genes Dev. 9:1586-1597.
5. Delude, R. L., M. J. Fenton, R. Savedra, Jr., P.-Y. Perera, S. N. Vogel, and D. T. Golenbock. 1994 CD-14 mediated translocation of nuclear factor-κB induced by lipopolysaccharide does not require tyrosine kinase activity. J. Biol. Chem. 269:22253-22260.
6. Didonato, J. A., F. Mercurio, and M. Karin. 1995. Phosphorylation of IκBα precedes but is not sufficient far its dissociation from NF-κB Mol Cell. Biol. 15:1302-1311.
7. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
8. d) mice respond to bacterial lipopolysaccharide by activating NF-κB. J. Leukocyte Biol. 57:174-179.
9. Ding, A., F. Porteu, E. Sanchez, and C. F. Nathan. 1990. Shared actions of endotoxin and Taxol on TNF receptors and TNF release. Science 248:370-372.
10. Duchow, J., A. Marchant, A. Crusiaux, C. Husson, C. Alonso-Vega, D. De Groote, P. Neve, and M. Goldman. 1993. Impaired phagocyte responses to lipopolysaccharide in paroxysmal nocturnal hemoglobinuria. Infect. Immun. 61:4280-4285.
11. Ertal, W., F. Krombach, J.-P. Kremer, D. Jarrar, V. Thiele, J. Eymann, S. Muenzing, E. Faist, K. Messmer, and F.-W. Schildberg. 1993. Mechanisms of cytokine cascade activation in patients with sepsis: normal cytokine transcription despite reduced CD14 receptor expression. Surgery (St. Louis) 114:243-251.
12. Gregner, J. A., R. J. Ulevitch, and P. S. Tobias. 1995. Lipopolysaccharide (LPS) signal transduction and clearance. J. Biol. Chem. 270:5320-5325.
13. d, macrophages. Mol. Med. 1:428-435.
14. Hogan, M. M., and S. N. Vogel. 1987. Lipid A-associated proteins provide an alternate "second signal" in the activation of recombinant interferon-γ-primed, C3H/HeJ macrophages to a fully tumoncidal state. J. Immunol. 139:3697-3702.
15. Hunninghake, G. W., B. G. Monks, L. J. Geist, M. M. Monick, M. A. Monroy, M. F. Stinski, A. C. Webb, J.-M. Dayer, P. E. Auron, and M. J. Fenton. 1992. The functional importance of a cap site-proximal region of the human prointerleukin 1β gene is defined by viral protein trans-activation. Mol. Cell. Biol. 12:3439-3448.
16. Hwang, S., and A. Ding. 1995 Activation of NF-κB in murine macrophages by Taxol. Cancer Biochem. Biophys. 14:265-272
17. a. Institute of Laboratory Animal Resources. 1985. Guide for the care and use of laboratory animals. DHEW publication number 85-23. National Research Council, Washington, D.C.
18. Juan, T. S.-C., E. Hailman, M. J. Kelley, L. A. Busse, E. Davy, C. J. Empig, L. O. Narhi, S. D. Wright, and H. S. Lichenstein. 1995. Identification of a lipopolysaccharide binding domain in CD 14 between ammo acids 57 and 64. J. Biol. Chem 270:5219-5224.
19. Kirikae, F., T. Kirikae, N. Qureshi, K. Takayama, D. C. Morrison, and M. Nakano. 1995. CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by Taxol in murine macrophages Infect Immun 63: 486-497.
20. Lenardo, M., and U. Siebenlist. 1994. Bcl-3-mediated nuclear regulation of the NF-κB trans-activating factor. Immunol. Today 15:145-147.
21. Libermann, T. A., and D. Baltimore. 1990. Activation of interleukin-6 gene expression through the NF-κB transcription factor Mol. Cell. Biol. 10:2327-2334.
22. Lin, Y., K. Brown, and U. Siebenlist. 1995. Activation of NF-κB requires proteolysis of the inhibitor IκB-α signal-induced phosphorylation of IκB-α alone does not release active NF-κB. Proc. Natl Acad. Sci USA 92:552-556.
23. Link, E., L. D. Kerr, R. Schreck, U. Zabel, I. Verma, and P. A. Baeuerle. 1992 Purified IκB-β is inactivated upon dephosphorylation. J Biol. Chem. 267:239-246
24. Lynn, W. A., and D. T. Golenbock. 1992. Lipopolysaccharide antagonists. Immunol. Today 13:271-276.
25. Manthey, C. L., M. E. Brandes, P.-Y. Perera, and S. N. Vogel. 1992. Taxol increases steady-state levels of LPS-inducible genes and protein-tyrosine phosphorylation in murine macrophages. J. Immunol 149:2459-2465.
26. d) macrophages. J. Immunol. 153:2653-2663.
27. Manthey, C. L., P.-Y. Perera, N. Qureshi, P. L. Stutz, T. A. Hamilton, and S. N. Vogel. 1993. Modulation of lipopolysaccharide-induced macrophage gene expression by Rhodobacter sphaeroides lipid A and SDZ 880.431. Infect Immun. 61:3518-3526.
28. Manthey, C. L., P.-Y. Perera, C. A. Salkowski, and S. N. Vogel. 1994. Taxol provides a second signal for murine macrophage tumoricidal activity. J. Immunol. 152:825-831.
29. Manthey, C. L., N. Qureshi, P. L. Stutz, and S. N. Vogel. 1993. Lipopolysaccharide antagonists block Taxol-induced signaling in murine macrophages. J. Exp. Med 178:695-702
30. Manthey, C. L., and S. N. Vogel. 1994. Taxol: a promising endotoxin research tool, J. Endotoxin Res. 1:189-198.
31. McGinley, M. D., L. O. Narhi, M. J. Kelley, E. Davy, J. Robinson, M. F. Rohde, S. D. Wright, and H. S. Lichenstein. 1995. CD14: physical properties and identification of an exposed site that is protected by lipopolysaccharide J. Biol. Chem. 270:5213-5218.
32. McIntire, F. C., H. W. Sievert, G. H. Barlow, R. A. Finley, and A. Y. Lee. 1967. Chemical, physical, and biological properties of a lipopolysaccharide from Eschenchia coli K-235. Biochemistry 6:2363-2372.
33. Morrison, D. C., and L. Leive. 1975. Fractions of lipopolysaccharide from Escherichia colt 0111:B4 prepared by two extraction procedures. J Biol. Chem. 250:2911-2919.
34. Nakayama, K., H. Shimizu, K. Mitomo, T. Watanabe, S.-I. Okamoto, and K.-I. Yamamoto. 1992 A lymphoid cell-specific nuclear factor containing c-Rel-like proteins preferentially interacts with interleukin-6 κB-related motifs whose activities are repressed in lymphoid cells. Mol. Cell. Biol. 12:1736-1746.
35. Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773-785.
36. Pugin, J., D. Heumann, A. Tomasz, V. V. Kravchenko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor Immunity 1: 509-516.
37. Qureshi, N., K. Takayama, K. C. Meyers, T. N. Kirkland, C. A. Bush, L. Chen, R. Wang, and R. J. Cotter. 1991 Chemical reduction of 3-oxo and unsaturated groups in fatty acids of diphosphoryl lipid A from the lipopolysaccharide of Rhodobacter sphaeroides: comparison of biological properties before and after reduction. J. Biol. Chem. 266:6532-6538
38. Sehreck, R., K. Albermann, and P. A. Baeuerle. 1992 Nuclear factor κB: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Rad Res. Commun. 17:221-237.
39. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with mini-extracts, prepared from a small number of cells. Nucleic Acids Res 17:6419.
40. Sha, C. W., H.-C. Liou, E. I. Tuomanen, and D. Baltimore. 1995 Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321-330.
41. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB Annu. Rev. Cell Biol. 10:405-455
42. Thanos, D., and T. Maniatis. 1995. NF-κB: a lesson in family values. Cell 80:529-532.
43. Tobias, P. S., and R. J. Ulevitch. 1994. Lipopolysaccharide-binding protein and CD14 in the lipopolysaccharide-dependent activation of cells. Chest 105:48S-50S.
44. Vinitsky, A., C. Michaud, J. C. Powers, and M. Orlowski. 1992. Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex. Biochemistry 31:9421-9428.
45. Vogel, S. N. 1992. The Lps gene: insights into the genetic and molecular basis of LPS responsiveness and macrophage differentiation, p 485-513 In B Beutler (ed), Tumor necrosis factors: the molecules and their emerging role in medicine. Raven Press, New York.
46. Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R. Ryseck, S. A. Lira, and R. Bravo. 1995 Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of Rel B, a member of the NF-κB/Rel family. Cell 80:331-340.
47. Wright, S. D. 1995. CD14 and innate recognition of bacteria. J. Immunol 155:6-8.
48. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990 CD14: a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.